SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus

BACKGROUND: Chemoradiotherapy is the standard of care for patients with oesophageal cancer unsuitable for surgery due to the presence of co-morbidity or extent of disease, and is a standard treatment option for patients with squamous cell carcinoma of the oesophagus. Modern regimens of chemoradiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurt, Christopher N, Nixon, Lisette S, Griffiths, Gareth O, Al-Mokhtar, Ruby, Gollins, Simon, Staffurth, John N, Phillips, Ceri J, Blazeby, Jane M, Crosby, Tom D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212828/
https://www.ncbi.nlm.nih.gov/pubmed/22035459
http://dx.doi.org/10.1186/1471-2407-11-466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212828/
https://www.ncbi.nlm.nih.gov/pubmed/22035459
http://dx.doi.org/10.1186/1471-2407-11-466

Ejemplares similares